Pacira Pharma (PCRX) Tops Q4 EPS by 12c, Revenue Beats; Offers FY20 Revenue Guidance

Go back to Pacira Pharma (PCRX) Tops Q4 EPS by 12c, Revenue Beats; Offers FY20 Revenue Guidance
PACIRA (NASDAQ: PCRX) Delayed: 23.51 --0 (-0%)
Previous Close $23.51    52 Week High $80.25 
Open $23.51    52 Week Low $30.25 
Day High $23.51    P/E N/A 
Day Low $23.51    EPS $-2.08 
Volume 497